bay h 4502 has been researched along with Tinea Pedis in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (40.91) | 18.7374 |
| 1990's | 5 (22.73) | 18.2507 |
| 2000's | 6 (27.27) | 29.6817 |
| 2010's | 2 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Esposito, L; Gorani, A; Veraldi, S | 1 |
| Eichenfield, LF; Friedlander, SF | 1 |
| Kanda, N; Mitsui, H; Nakai, K; Ohnishi, T; Suzuki, T; Watanabe, S | 1 |
| Algueró, M; Boncompte, E; Izquierdo, I; Noguera, X; Pereda, J | 1 |
| Crawford, F | 1 |
| Higashi, N; Kagawa, S; Nishikawa, T; Nishimoto, K; Ogawa, H; Takahashi, H; Takiuchi, I; Watanabe, S; Yamaguchi, H | 1 |
| Belli, L; Castro, JM; Galimberti, RL; Negroni, R; Rohwedder, R; Tuculet, MA | 2 |
| Binder, D; Frank, H; Schubert, E | 1 |
| Arikawa, J; Chi, HI; Goto, A; Kawano, S; Kubo, M; Matsukawa, A; Minami, H; Nakamura, E; Nakamura, Y; Nakauchi, Y; Nishiyama, Y; Osada, A; Shimozuma, M; Soma, Y; Takahashi, H; Tamaki, K; Teduka, M; Tomizawa, T; Uchida, K; Ueda, Y; Wakukawa, M; Watanabe, S; Yamaguchi, H | 1 |
| Arikawa, J; Chi, HI; Goto, A; Kawano, S; Matsukawa, A; Minami, H; Nakamura, E; Nakamura, Y; Nakauchi, Y; Nishiyama, Y; Osada, A; Shimozuma, M; Soma, Y; Takahashi, H; Tamaki, K; Teduka, M; Tomizawa, T; Uchida, K; Ueda, Y; Wakukawa, M; Watanabe, S; Yamaguchi, H | 1 |
| Fujita, S; Itoyama, T; Uchida, K; Yamaguchi, H | 1 |
| Nishiyama, S; Tanuma, H | 1 |
| Abe, M; Doi, M; Katsuoka, K; Kume, H; Nishiyama, S; Sato, N; Tanuma, H | 1 |
| Ito, T; Majima, T; Nakashima, T; Nozawa, A; Yamaguchi, H | 1 |
| Konaka, S; Ohmi, T; Uchida, M; Yamaguchi, H | 1 |
| Richardson, MD; Scott, EM; Wheatley, D | 1 |
| Kokelj, F; Minkusch, E | 1 |
| Head, ES; Macdonald, E; Tschen, E | 1 |
| Bojanovsky, A; Haas, P | 1 |
| del Palacio Hernanz, A; Iglesias Diez, L; López Gómez, S | 1 |
| Adriaans, B; Gentles, JC; Roberts, DT | 1 |
2 review(s) available for bay h 4502 and Tinea Pedis
| Article | Year |
|---|---|
Pediatric Onychomycosis: The Emerging Role of Topical Therapy.
Topics: Administration, Topical; Adult; Age Factors; Antifungal Agents; Child; Ciclopirox; Family; Humans; Imidazoles; Incidence; Ketoconazole; Lacquer; Morpholines; Naphthalenes; Onychomycosis; Prevalence; Pyridones; Recurrence; Terbinafine; Tinea Pedis; Treatment Outcome | 2017 |
Athlete's foot.
Topics: Allylamine; Antifungal Agents; Clotrimazole; Econazole; Humans; Imidazoles; Miconazole; Naphthalenes; Terbinafine; Tinea Pedis | 2005 |
9 trial(s) available for bay h 4502 and Tinea Pedis
| Article | Year |
|---|---|
Efficacy of flutrimazole 1% powder in the treatment of tinea pedis.
Topics: Adolescent; Adult; Antifungal Agents; Clotrimazole; Double-Blind Method; Female; Humans; Imidazoles; Male; Powders; Tinea Pedis; Treatment Outcome; Trichophyton | 2003 |
A comparative clinical study between 2 weeks of luliconazole 1% cream treatment and 4 weeks of bifonazole 1% cream treatment for tinea pedis.
Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Female; Humans; Imidazoles; Male; Middle Aged; Ointments; Tinea Pedis; Treatment Outcome; Trichophyton | 2006 |
Treatment of tinea pedis interdigitalis with bifonazole, 1% gel.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Clinical Trials as Topic; Drug Tolerance; Female; Humans; Imidazoles; Male; Middle Aged; Tinea Pedis; Trichophyton | 1984 |
Prophylaxis of tinea pedis interdigitalis with bifonazole, 1% powder.
Topics: Adult; Antifungal Agents; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Imidazoles; Male; Powders; Recurrence; Tinea Pedis; Trichophyton | 1984 |
[Fundamental and clinical studies on the efficacy of bifonazole in patients with tinea pedis at 10 years after approval. Part 2. Clinical evaluation].
Topics: Adult; Aged; Antifungal Agents; Drug Resistance, Microbial; Female; Humans; Imidazoles; Male; Middle Aged; Tinea Pedis; Trichophyton | 1996 |
Clinical evaluation of bifonazole for moccasin-type tinea pedis.
Topics: Adult; Aged; Antifungal Agents; Drug Therapy, Combination; Female; Humans; Imidazoles; Japan; Keratosis; Male; Middle Aged; Tinea Pedis; Urea | 1997 |
Bifonazole (Mycospor cream) in the treatment of moccasin-type tinea pedis. Comparison between combination therapy of bifonazole cream + 10% urea ointment (Urepearl) and occlusive dressing therapy with the same agents.
Topics: Administration, Topical; Adult; Aged; Antifungal Agents; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Imidazoles; Male; Middle Aged; Occlusive Dressings; Ointments; Time Factors; Tinea Pedis; Urea | 2000 |
[Antimycotic effect of naftifin in tinea pedis. Comparative double-blind study with bifonazole].
Topics: Adult; Allylamine; Amines; Antifungal Agents; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Imidazoles; Male; Middle Aged; Ointments; Tinea Pedis | 1985 |
A comparative study of once daily bifonazole cream versus twice daily miconazole cream in the treatment of tinea pedis.
Topics: Adult; Antifungal Agents; Clinical Trials as Topic; Humans; Imidazoles; Miconazole; Random Allocation; Tinea Pedis | 1985 |
11 other study(ies) available for bay h 4502 and Tinea Pedis
| Article | Year |
|---|---|
Tinea pedis acquired in mosques?
Topics: Adult; Antifungal Agents; Child; Female; Humans; Imidazoles; Italy; Male; Ointments; Tinea Pedis; Travel; Trichophyton; Turkey | 2018 |
[Usefulness of bifonazole for treatment of tinea pedis in the 20th year after approval].
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antifungal Agents; Drug Approval; Female; Humans; Imidazoles; Male; Middle Aged; Product Surveillance, Postmarketing; Time Factors; Tinea Pedis; Treatment Outcome; Young Adult | 2009 |
[Bifonazole for the topical treatment of surface mycoses--progress!].
Topics: Administration, Topical; Antifungal Agents; Candidiasis, Cutaneous; Dermatomycoses; Female; Humans; Imidazoles; Male; Tinea; Tinea Pedis | 1984 |
[Preclinical and clinical studies on the efficacy of bifonazole in patients with tinea pedis at 10 years after approval. Part 1. Susceptibility to bifonazole of clinical isolates of dermatophytes].
Topics: Antifungal Agents; Clotrimazole; Drug Resistance, Microbial; Humans; Imidazoles; Time Factors; Tinea Pedis; Trichophyton | 1996 |
Therapeutic effects of omoconazole nitrate on experimental tinea pedis, an intractable dermatophytosis, in guinea-pigs.
Topics: Animals; Antifungal Agents; Female; Guinea Pigs; Imidazoles; Tinea Pedis | 1997 |
Development of a new medium useful for the recovery of dermatophytes from clinical specimens by minimizing the carryover effect of antifungal agents.
Topics: Administration, Topical; Agar; Animals; Antifungal Agents; Culture Media; Disease Models, Animal; Female; Guinea Pigs; Heterocyclic Compounds; Imidazoles; Microbiological Techniques; Naphthalenes; Phosphatidylcholines; Polysorbates; Surface-Active Agents; Terbinafine; Tinea Pedis; Trichophyton | 2002 |
Antifungal activity of the new agent latoconazole in two tinea models.
Topics: Animals; Antifungal Agents; Clotrimazole; Guinea Pigs; Heterocyclic Compounds; Imidazoles; Male; Microbial Sensitivity Tests; Tinea Pedis; Tolnaftate; Trichophyton | 1991 |
Tinea infections treated with bifonazole gel.
Topics: Gels; Humans; Imidazoles; Tinea; Tinea Pedis | 1988 |
[1 percent bifonazole cream in the treatment of athlete's foot. Open clinical study of 40 cases].
Topics: Adolescent; Adult; Antifungal Agents; Drug Evaluation; Female; Humans; Imidazoles; Male; Middle Aged; Ointments; Tinea Pedis | 1987 |
Dual infection of the toe web caused by Trichophyton rubrum and Microsporum canis.
Topics: Adult; Humans; Imidazoles; Male; Microsporum; Tinea Pedis; Toes; Trichophyton | 1986 |
[Treatment of interdigital tinea pedis using a solution of 1:100 bifonazole (Bay h 4502)].
Topics: Administration, Topical; Adolescent; Adult; Aged; Drug Administration Schedule; Evaluation Studies as Topic; Female; Humans; Imidazoles; Male; Middle Aged; Solutions; Tinea Pedis; Trichophyton | 1985 |